In 2019 the Walter Reed Army Institute of Research opened a protocol that will be the first observational HIV study conducted in the Kingdom of Jordan. EIDB is collaborating with partners on the study, RV505, which seeks to understand the evolving HIV epidemic in Jordan; gathering information on HIV risk factors, outcomes, genotypes and drug resistance profiles.
This is the first study to come out of the Partnership for Research in the Middle East (PRIME), a WRAIR collaborative initiative led by the Emerging Infectious Diseases Branch (EIDB) with the Jordanian Royal Medical Services and the Jordan Ministry of Health.
PRIME, headed by EIDB, launched in 2017 with initiatives focused on training, improving biopreparedness and upgrading laboratories and equipment. EIDB won a $1 million award to support severe acute respiratory infection (SARI) threat characterization in military treatment facilities across the Kingdom of Jordan. Other future research activities will focus on emerging infectious diseases including studies on survivors of locally reportable diseases and acute febrile illness.